Dere Willard H
SEC-identified person · CIK 1311569 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Metagenomi, Inc. MGX | Director | filed 2024 - 2026 |
| Biomarin Pharmaceutical INC BMRN | Director | filed 2016 - 2026 |
| Mersana Therapeutics, Inc. [MRSN] | Director | filed 2018 - 2026 |
| Seres Therapeutics, Inc. MCRB | Director | filed 2017 - 2025 |
| Radius Health, Inc. RDUS | Director | filed 2014 - 2022 |
| Tranzyme INC TZYM | Director | filed 2016 - 2017 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.